FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000650466> ?p ?o ?g. }

• W2000650466 endingPage "173" @default.
• W2000650466 startingPage "163" @default.
• W2000650466 abstract "Abstract Objective We compared the effectiveness of lower‐dose ( LD ) (450 mg/day for 6 months) to standard‐dose ( SD ) (900 mg/day for 6 months) valganciclovir ( VGCV ) prophylaxis for prevention of cytomegalovirus ( CMV ) infection and disease in high‐risk CMV donor‐positive/recipient‐negative (D+/R−) kidney recipients. Methods We performed a single‐center, retrospective cohort study, in a 750‐bed academic medical center, involving a total of 90 evaluable CMV high‐risk kidney recipients. All patients were retrospectively followed from day of transplantation to November 1, 2012, or to the development of CMV infection or disease, death, or loss to follow‐up. CMV screening was only done if suggestive symptoms or abnormal laboratory values were present. Our immunosuppressive protocol otherwise did not differ between periods. Results In total, 45 consecutive eligible patients initiated SD prophylaxis in the 22 months before the institutional protocol change regarding CMV prophylaxis. One patient developed CMV infection in the setting of non‐adherence. In the 16 months after the protocol update, 45 consecutive eligible patients receiving LD prophylaxis were evaluated: 6 developed CMV infection while receiving prophylaxis ( P = 0.11). Ganciclovir ( GCV )‐resistant infection was confirmed in 1 patient in the LD prophylaxis group. Late‐onset CMV infection or disease occurred in 11 patients (24%) in the SD group and in 12 patients (27%) in the LD group ( P = 0.86). More patients in the SD group developed leukopenia (75% vs. 44%, P < 0.01). During the study period, no significant differences were seen between the groups in mean mg/kg exposure to rabbit anti‐thymocyte globulin induction courses, mean tacrolimus troughs, number of rejection episodes, mean estimated renal function, graft survival, or patient survival. Overall mean follow‐up (± standard deviation) was 357 days (± 53) in the SD group and 320 days (± 103) in the LD group ( P = 0.03). Conclusion Breakthrough CMV infection while receiving VGCV prophylaxis occurred more often after the institutional protocol revision to LD VGCV prophylaxis. Given our concern for increased risk of breakthrough infection and GCV resistance when prophylaxis is under‐dosed, our institutional protocols were revised back to SD prophylaxis for all CMV D+/R− kidney transplant recipients." @default.
• W2000650466 created "2016-06-24" @default.
• W2000650466 creator A5023701084 @default.
• W2000650466 creator A5024826112 @default.
• W2000650466 creator A5035337413 @default.
• W2000650466 creator A5036989582 @default.
• W2000650466 creator A5048636386 @default.
• W2000650466 creator A5055397048 @default.
• W2000650466 date "2015-02-06" @default.
• W2000650466 modified "2023-10-03" @default.
• W2000650466 title "Increased risk of breakthrough infection among cytomegalovirus donor-positive/recipient-negative kidney transplant recipients receiving lower-dose valganciclovir prophylaxis" @default.
• W2000650466 cites W1501685127 @default.
• W2000650466 cites W1519669488 @default.
• W2000650466 cites W1599285274 @default.
• W2000650466 cites W1982917487 @default.
• W2000650466 cites W1982960418 @default.
• W2000650466 cites W1986365927 @default.
• W2000650466 cites W1996228974 @default.
• W2000650466 cites W1997139070 @default.
• W2000650466 cites W1997749858 @default.
• W2000650466 cites W2000880523 @default.
• W2000650466 cites W2023970757 @default.
• W2000650466 cites W2031832264 @default.
• W2000650466 cites W2057711667 @default.
• W2000650466 cites W2059181697 @default.
• W2000650466 cites W2059381890 @default.
• W2000650466 cites W2059471557 @default.
• W2000650466 cites W2071772149 @default.
• W2000650466 cites W2083104094 @default.
• W2000650466 cites W2087762810 @default.
• W2000650466 cites W2089673255 @default.
• W2000650466 cites W2092091932 @default.
• W2000650466 cites W2096636741 @default.
• W2000650466 cites W2098773501 @default.
• W2000650466 cites W2117144688 @default.
• W2000650466 cites W2129477930 @default.
• W2000650466 cites W2131672675 @default.
• W2000650466 cites W2134087037 @default.
• W2000650466 cites W2142261360 @default.
• W2000650466 cites W2160479322 @default.
• W2000650466 cites W2168046861 @default.
• W2000650466 cites W2314294836 @default.
• W2000650466 doi "https://doi.org/10.1111/tid.12349" @default.
• W2000650466 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25661673" @default.
• W2000650466 hasPublicationYear "2015" @default.
• W2000650466 type Work @default.
• W2000650466 sameAs 2000650466 @default.
• W2000650466 citedByCount "58" @default.
• W2000650466 countsByYear W20006504662015 @default.
• W2000650466 countsByYear W20006504662016 @default.
• W2000650466 countsByYear W20006504662017 @default.
• W2000650466 countsByYear W20006504662018 @default.
• W2000650466 countsByYear W20006504662019 @default.
• W2000650466 countsByYear W20006504662020 @default.
• W2000650466 countsByYear W20006504662021 @default.
• W2000650466 countsByYear W20006504662022 @default.
• W2000650466 countsByYear W20006504662023 @default.
• W2000650466 crossrefType "journal-article" @default.
• W2000650466 hasAuthorship W2000650466A5023701084 @default.
• W2000650466 hasAuthorship W2000650466A5024826112 @default.
• W2000650466 hasAuthorship W2000650466A5035337413 @default.
• W2000650466 hasAuthorship W2000650466A5036989582 @default.
• W2000650466 hasAuthorship W2000650466A5048636386 @default.
• W2000650466 hasAuthorship W2000650466A5055397048 @default.
• W2000650466 hasConcept C126322002 @default.
• W2000650466 hasConcept C141071460 @default.
• W2000650466 hasConcept C167135981 @default.
• W2000650466 hasConcept C203014093 @default.
• W2000650466 hasConcept C2522874641 @default.
• W2000650466 hasConcept C2776317777 @default.
• W2000650466 hasConcept C2776409557 @default.
• W2000650466 hasConcept C2776688490 @default.
• W2000650466 hasConcept C2776694085 @default.
• W2000650466 hasConcept C2777732132 @default.
• W2000650466 hasConcept C2777965375 @default.
• W2000650466 hasConcept C2778653478 @default.
• W2000650466 hasConcept C2779820661 @default.
• W2000650466 hasConcept C2780073493 @default.
• W2000650466 hasConcept C2780303639 @default.
• W2000650466 hasConcept C2780727368 @default.
• W2000650466 hasConcept C2780873365 @default.
• W2000650466 hasConcept C2911091166 @default.
• W2000650466 hasConcept C71924100 @default.
• W2000650466 hasConcept C72563966 @default.
• W2000650466 hasConcept C90924648 @default.
• W2000650466 hasConceptScore W2000650466C126322002 @default.
• W2000650466 hasConceptScore W2000650466C141071460 @default.
• W2000650466 hasConceptScore W2000650466C167135981 @default.
• W2000650466 hasConceptScore W2000650466C203014093 @default.
• W2000650466 hasConceptScore W2000650466C2522874641 @default.
• W2000650466 hasConceptScore W2000650466C2776317777 @default.
• W2000650466 hasConceptScore W2000650466C2776409557 @default.
• W2000650466 hasConceptScore W2000650466C2776688490 @default.
• W2000650466 hasConceptScore W2000650466C2776694085 @default.
• W2000650466 hasConceptScore W2000650466C2777732132 @default.
• W2000650466 hasConceptScore W2000650466C2777965375 @default.
• W2000650466 hasConceptScore W2000650466C2778653478 @default.
• W2000650466 hasConceptScore W2000650466C2779820661 @default.

• next